These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 12954158)

  • 1. Effect of treatment with losartan on cardiovascular autonomic and large sensory nerve fiber function in individuals with diabetes mellitus: a 1-year randomized, controlled trial.
    Maser RE; Lenhard MJ
    J Diabetes Complications; 2003; 17(5):286-91. PubMed ID: 12954158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity is not a confounding factor for performing autonomic function tests in individuals with diabetes mellitus.
    Maser RE; Lenhard MJ
    Diabetes Obes Metab; 2002 Mar; 4(2):113-7. PubMed ID: 11940108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurable deficit of autonomic and sensory nerve function in asymptomatic diabetic patients.
    Piaggesi A; Castro Lòpez E; Bini L; Benzi L; Giampietro O; Schipani E; Navalesi R
    J Diabetes Complications; 1992; 6(3):157-62. PubMed ID: 1472740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of age and diabetes mellitus on nerve function.
    Maser RE; Laudadio C; DeCherney GS
    J Am Geriatr Soc; 1993 Nov; 41(11):1202-4. PubMed ID: 8227894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ponalrestat, an aldose reductase inhibitor, on neutrophil killing of Escherichia coli and autonomic function in patients with diabetes mellitus.
    Boland OM; Blackwell CC; Clarke BF; Ewing DJ
    Diabetes; 1993 Feb; 42(2):336-40. PubMed ID: 8425670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study.
    Bakris GL; Weir MR; Shanifar S; Zhang Z; Douglas J; van Dijk DJ; Brenner BM;
    Arch Intern Med; 2003 Jul; 163(13):1555-65. PubMed ID: 12860578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vibratory thresholds correlation with systolic blood pressure in diabetic women.
    Maser RE; Lenhard MJ; DeCherney GS
    Am J Hypertens; 1997 Sep; 10(9 Pt 1):1044-8. PubMed ID: 9324111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autonomic function and baroreflex sensitivity during angiotensin-converting enzyme inhibition or angiotensin II AT-1 receptor blockade in essential hypertensive patients.
    Guasti L; Petrozzino MR; Mainardi LT; Grimoldi P; Zanotta D; Garganico D; Diolisi A; Simoni C; Grandi AM; Gaudio G; Cerutti S; Venco A
    Acta Cardiol; 2001 Oct; 56(5):289-95. PubMed ID: 11712824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FimAsartaN proTeinuriA SusTaIned reduCtion in comparison with losartan in diabetic chronic kidney disease (FANTASTIC): study protocol for randomized controlled trial.
    Kim JY; Son JW; Park S; Yoo TH; Kim YJ; Ryu DR; Chin HJ
    Trials; 2017 Dec; 18(1):632. PubMed ID: 29284530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homocysteine levels are not associated with cardiovascular autonomic function in elderly Caucasian subjects without or with type 2 diabetes mellitus: the Hoorn Study.
    Spoelstra-De Man AM; Smulders YM; Dekker JM; Heine RJ; Bouter LM; Nijpels G; Stehouwer CD
    J Intern Med; 2005 Dec; 258(6):536-43. PubMed ID: 16313477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of losartan, compared with atenolol, on endothelial function and oxidative stress in patients with type 2 diabetes and hypertension.
    Flammer AJ; Hermann F; Wiesli P; Schwegler B; Chenevard R; Hürlimann D; Sudano I; Gay S; Neidhart M; Riesen W; Ruschitzka F; Lüscher TF; Noll G; Lehmann R
    J Hypertens; 2007 Apr; 25(4):785-91. PubMed ID: 17351370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Losartan, an angiotensin type 1 receptor inhibitor, and endothelial vasodilator function in Type 1 diabetes mellitus.
    Collis J; Cheetham C; Dembo L; O'Driscoll J; Stanton K; Taylor R; Green D
    Diabet Med; 2000 Jul; 17(7):553-4. PubMed ID: 10972591
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibodies to glutamic acid decarboxylase and peripheral nerve function in type 1 diabetes.
    Hoeldtke RD; Bryner KD; Hobbs GR; Horvath GG; Riggs JE; Christie I; Ganser G; Marcovina SM; Lernmark A
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3297-308. PubMed ID: 10999825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.
    Brenner BM; Cooper ME; de Zeeuw D; Keane WF; Mitch WE; Parving HH; Remuzzi G; Snapinn SM; Zhang Z; Shahinfar S;
    N Engl J Med; 2001 Sep; 345(12):861-9. PubMed ID: 11565518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Association Between Cardiovascular Autonomic Function and Changes in Kidney and Myocardial Function in Type 2 Diabetes and Healthy Controls.
    Laursen JC; Rasmussen IKB; Zobel EH; Hasbak P; von Scholten BJ; Holmvang L; Ripa RS; Hansen CS; Frimodt-Moeller M; Kjaer A; Rossing P; Hansen TW
    Front Endocrinol (Lausanne); 2021; 12():780679. PubMed ID: 34966359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of losartan on microalbuminuria in normotensive patients with type 2 diabetes mellitus. A randomized clinical trial.
    Zandbergen AA; Baggen MG; Lamberts SW; Bootsma AH; de Zeeuw D; Ouwendijk RJ
    Ann Intern Med; 2003 Jul; 139(2):90-6. PubMed ID: 12859158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of losartan in diabetic patients in the primary care setting: review of the results in LIFE and RENAAL.
    Egan B; Gleim G; Panish J
    Curr Med Res Opin; 2004 Dec; 20(12):1909-17. PubMed ID: 15701209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Albuminuria is a target for renoprotective therapy independent from blood pressure in patients with type 2 diabetic nephropathy: post hoc analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial.
    Eijkelkamp WB; Zhang Z; Remuzzi G; Parving HH; Cooper ME; Keane WF; Shahinfar S; Gleim GW; Weir MR; Brenner BM; de Zeeuw D
    J Am Soc Nephrol; 2007 May; 18(5):1540-6. PubMed ID: 17409317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of thermal perception thresholds with cardiovascular autonomic function in diabetes.
    Piha SJ; Halonen JP; Tamminen T
    J Diabetes Complications; 1993; 7(1):39-43. PubMed ID: 8481549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of angiotensin II receptor antagonist on endothelial vasomotor function and urinary albumin excretion in type 2 diabetic patients with microalbuminuria.
    Tan KC; Chow WS; Ai VH; Lam KS
    Diabetes Metab Res Rev; 2002; 18(1):71-6. PubMed ID: 11921421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.